| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |